 |
市場調査レポート
商品コード
1463418
デジタルパソロジーの世界市場規模、シェア、成長分析、製品別、用途別 - 産業予測、2024～2031年Global Digital Pathology Market Size, Share, Growth Analysis, By Product(Software, device), By Application(Drug discovery & development, academic research) - Industry Forecast 2024-2031 |
||||||
| デジタルパソロジーの世界市場規模、シェア、成長分析、製品別、用途別 - 産業予測、2024～2031年 |
|
出版日: 2024年04月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のデジタルパソロジーの市場規模は、2022年に9億7,000万米ドルとなり、予測期間中（2024かrあ2031年）のCAGRは7.8%で、2023年の10億5,000万米ドルから、2031年までには19億1,000万米ドルに成長する見通しです。
医療診断・研究産業の急拡大分野である世界のデジタルパソロジー市場は、より精密で効果的な診断機器へのニーズの高まりに後押しされています。病理標本はデジタル化され、デジタルパソロジーの一環として分析されます。これにより、病理医の共同作業が容易になり、より正確な診断が可能になり、納期も短縮されます。より正確で焦点を絞った診断が必要とされる個別化医療へのニーズの高まりは、デジタルパソロジー市場を推進する主要な要因の一つです。さらに、より効果的な診断機器へのニーズは、がんのような慢性疾患の罹患率の上昇に後押しされています。診断効率と精度を向上させる可能性があるため、デジタルパソロジー診断におけるAIと機械学習技術の利用も市場拡大を促進すると予想されています。しかし、市場には困難もあります。特に発展途上国では、デジタルパソロジー装置の高価なコストと、それを運用するための訓練を受けた人材の必要性によって、導入が妨げられる可能性があります。また、データの安全性やプライバシーに関する懸念も、業界拡大の障害となる可能性があります。こうした障害にもかかわらず、この業界には多くの発展と革新の展望があります。デジタルパソロジーがクラウド・コンピューティングや遠隔医療のような他の技術と統合されることで、効率向上やチームワークの新たな可能性が開かれます。学術機関や研究機関におけるデジタルパソロジープラットフォームや遠隔病理診断の利用の増加により、市場拡大の新たな展望が開けています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要な投資の分析
- 主要な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
デジタルパソロジーの世界市場：製品別
- 市場概要
- ソフトウェア
- デバイス
- ストレージシステム
デジタルパソロジーの世界市場：用途別
- 市場概要
- 医薬品の発見・開発
- 学術調査
- 病気の診断
デジタルパソロジーの世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Philips Healthcare（Netherlands）
- Leica Biosystems（Germany）
- Roche Diagnostics（Switzerland）
- Hamamatsu Photonics（Japan）
- 3DHISTECH（Hungary）
- Ventana Medical Systems（US）
- GE Healthcare（US）
- Apollo Enterprise Imaging（US）
- Olympus Corporation（Japan）
- Mikroscan Technologies（US）
- Inspirata（US）
- PerkinElmer（US）
- Huron Digital Pathology（Canada）
- Sectra AB（Sweden）
- PathAI（US）
- Indica Labs（US）
- F. Hoffmann-La Roche（Switzerland）
- Nikon Corporation（Japan）
- Danaher Corporation（US）
- Visiopharm（Denmark）
Global Digital Pathology Market size was valued at USD 0.97 billion in 2022 and is poised to grow from USD 1.05 billion in 2023 to USD 1.91 billion by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).
A rapidly expanding segment of the medical diagnostics and research industry, the worldwide digital pathology market is being propelled by the growing need for more precise and effective diagnostic instruments. Pathology specimens are digitized and analyzed as part of digital pathology, which facilitates simpler pathologist collaboration, more accurate diagnoses, and quicker turnaround times. The increasing need for individualized medicine, which necessitates more accurate and focused diagnostics, is one of the major factors propelling the digital pathology market. Furthermore, the need for more effective diagnostic instruments is being driven by the rising incidence of chronic illnesses like cancer. Due to the potential to improve diagnostic efficiency and accuracy, the use of AI and machine learning technologies in digital pathology is also anticipated to propel market expansion. But there are difficulties in the market. Adoption may be hampered by the expensive cost of digital pathology equipment and the requirement for trained individuals to run them, especially in developing nations. Concerns about data security and privacy could also be a barrier to industry expansion. Notwithstanding these obstacles, there are a lot of development and innovation prospects in the industry. Digital pathology's integration with other technologies-like cloud computing and telemedicine-opens up new possibilities for efficiency gains and teamwork. There are fresh prospects for market expansion due to the increasing use of digital pathology platforms and remote pathology consultations in academic and research institutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Digital Pathology Market Segmental Analysis
Global Digital Pathology Market is segmented on the basis of product, application, and region. By product, the market is segmented into software, device, and storage systems. By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Digital Pathology Market
The introduction of digital pathology is being propelled by ongoing developments in digital imaging technologies, including whole-slide imaging (WSI), high-resolution scanners, and image processing software. Diagnoses made with greater accuracy and efficiency are made possible by these technical advancements, which also provide better image quality, quicker scanning times, and stronger analytic tools. Artificial intelligence (AI) tools and deep learning algorithms, for instance, have made it possible to automatically analyze images and identify anomalies in pathology slides, which helps pathologists make decisions.
Restraints in the Global Digital Pathology Market
Digital pathology system implementation necessitates a large initial investment in software, storage infrastructure, and scanners. Digitizing slides, keeping up digital archives, and hiring staff can be expensive, especially for smaller labs or medical institutes with tight resources. Furthermore, several businesses may face difficulties incorporating digital pathology into their current laboratory operations and meeting the requirements for infrastructure changes and IT support.
Market Trends of the Global Digital Pathology Market
Telepathology and Remote Consultation: With the growing use of telepathology, pathologists are able to collaborate and offer professional opinions from a distance through remote diagnosis and consultation. Since telepathology reduces pathologists' exposure risk and allows for remote working, it has become more popular during the COVID-19 epidemic. For instance, pathologists can participate in interdisciplinary tumor boards, evaluate and discuss cases with colleagues virtually, or offer consults to underserved areas or regions lacking in pathology knowledge.
Artificial Intelligence and Machine Learning Integration: A noteworthy trend is the incorporation of AI and machine learning algorithms into digital pathology systems. Pathologists can benefit from AI's assistance with activities including automated tissue recognition, anomaly detection, biomarker quantification, and disease outcome prediction. With the use of these technologies, pathology diagnosis could become more effective, accurate, and repeatable. AI algorithms, for example, can assist in the automatic identification of particular features in histopathology pictures or the detection and classification of cancer cells.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Digital Pathology Market by Product
- Market Overview
- Software
- device
- and storage systems
Global Digital Pathology Market by Application
- Market Overview
- Drug discovery & development
- academic research
- and disease diagnosis
Global Digital Pathology Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Leica Biosystems (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hamamatsu Photonics (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3DHISTECH (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ventana Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Apollo Enterprise Imaging (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mikroscan Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inspirata (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Huron Digital Pathology (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sectra AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PathAI (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Indica Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nikon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Visiopharm (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
